lawrence steinman
Stanford University
H-index: 141
North America-United States
Top articles of lawrence steinman
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis | Nature Neuroscience | Marius Marc-Daniel Mader Alan Napole Danwei Wu Micaiah Atkins Alexa Scavetti | 2024/3/21 |
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue | Nature Communications | Hunter A Martinez Ievgen Koliesnik Gernot Kaber Jacqueline K Reid Nadine Nagy | 2024/2/20 |
Long-term Efficacy of the Sphingosine 1-Phosphate Receptor Modulator Ozanimod by Age Category in Patients with Relapsing Multiple Sclerosis: Final Results from Two Phase 3 … | Lawrence Steinman Krzysztof Selmaj Giancarlo Comi Amit Bar-Or Douglas Arnold | 2024/4/14 | |
Hunger guides immunity to friend versus foe | Nature Neuroscience | Noga Or-Geva Lawrence Steinman | 2024/2/15 |
Absolute Lymphocyte Count Around Infections During Phase 3 and Open-label Extension Trials of Ozanimod in Participants with Relapsing Multiple Sclerosis (P10-6.013) | Hans-Peter Hartung Lawrence Steinman Amit Bar-Or James Sheffield Sarah Harris | 2024/4/14 | |
A Novel Mouse Model of Cerebral Demyelination in X-linked Adrenoleukodystrophy Highlights NLRP3 Activation in Lesion Pathogenesis (P11-4.004) | Ezzat Hashemi Isha Srivastava Alejandro Aguirre Ezra Yoseph Esha Kaushal | 2024/4/14 | |
Ublituximab Reduces Thalamic Volume Loss and New Lesion Formation in Participants of the ULTIMATE I & II Phase 3 Studies | Douglas L Arnold Lawrence Steinman Hans Peter Hartung Krzysztof Selmaj Lily Lee | 2023/10/1 | |
Ublituximab efficacy in treatment-naive participants with relapsing multiple sclerosis in the phase 3 ULTIMATE I and II studies (P6-3.015) | Lawrence Steinman Edward Fox Hans-Peter Hartung Enrique Alvarez Peiqing Qian | 2023/4/25 | |
An intrinsically disordered protein, osteopontin, driving neuropathology in Alzheimer’s dementia | Proceedings of the National Academy of Sciences | Lawrence Steinman | 2023/2/7 |
Biomarkers for assessing subjects with multiple sclerosis | 2023/8/29 | ||
Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis (P5-3.010) | Douglas L Arnold Leorah Freeman Hans-Peter Hartung Xavier Montalbán Jeffrey A Cohen | 2023/4/25 | |
Treatment of neuroinflammatory disease | 2023/1/19 | ||
Elevated α5 integrin expression on myeloid cells in motor areas in amyotrophic lateral sclerosis is a therapeutic target | Proceedings of the National Academy of Sciences | Aude Chiot Shanu F Roemer Lisa Ryner Alina Bogachuk Katie Emberley | 2023/8/8 |
A Phase 1 Study of Oral Vitamin D3 in Boys and Young Men With X-Linked Adrenoleukodystrophy | Neurology: Genetics | Keith P Van Haren Kristen Cunanan Avni Awani Meng Gu Dalia Peña | 2023/3/31 |
Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease | Lawrence Steinman Roberto Patarca William Haseltine | 2023/1/18 | |
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity | Proceedings of the National Academy of Sciences | Sharon A Sagan Zahra Moinfar Carson E Moseley Ravi Dandekar Collin M Spencer | 2023/7/25 |
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis | Hans-Peter Hartung Bruce AC Cree Michael Barnett Sven G Meuth Amit Bar-Or | 2023/11/29 | |
Augmentation of a neuroprotective myeloid state by hematopoietic cell transplantation | bioRxiv | Marius Marc-Daniel Mader Alan Napole Danwei Wu Yohei Shibuya Alexa Scavetti | 2023/3/12 |
Roadmap for understanding mechanisms on how Epstein–Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials | Tobias V Lanz William H Robinson Peggy P Ho Lawrence Steinman | 2023 | |
Relationship Between Infections and Absolute Lymphocyte Count During Phase 3 and Open-label Extension Trials of Ozanimod in Patients With Relapsing Multiple Sclerosis (P7-3.002) | Hans-Peter Hartung Lawrence Steinman Amit Bar-Or James K Sheffield Sarah Harris | 2023/4/25 |
